134 related articles for article (PubMed ID: 10355534)
1. Crosslinking of cellular DNA by nitracrine and furocoumarin derivatives.
Studzian K; Tołwińska-Stańczyk Z; Wilmańska D; Palumbo M; Gniazdowski M
Neoplasma; 1999; 46(1):50-3. PubMed ID: 10355534
[TBL] [Abstract][Full Text] [Related]
2. Nitracrine and its congeners--an overview.
Gniazdowski M; Szmigiero L
Gen Pharmacol; 1995 May; 26(3):473-81. PubMed ID: 7789719
[TBL] [Abstract][Full Text] [Related]
3. Nitracrine N-oxides: effects of variations in the nature of the side chain N-oxide on hypoxia-selective cytotoxicity.
Lee HH; Wilson WR; Denny WA
Anticancer Drug Des; 1999 Dec; 14(6):487-97. PubMed ID: 10834270
[TBL] [Abstract][Full Text] [Related]
4. In vitro DNA crosslinking by Ledakrin, an antitumor derivative of 1-nitro-9-aminoacridine.
Bartoszek A; Dackiewicz P; Składanowski A; Konopa J
Chem Biol Interact; 1997 Feb; 103(2):141-51. PubMed ID: 9055872
[TBL] [Abstract][Full Text] [Related]
5. Intercalation model for DNA-cross linking in a 1-nitro-9-aminoacridine derivative, an analog of the antitumor agent "ledakrin" (nitracrine).
Stallings WC; Glusker JP; Carrell HL; Bogucka-Ledóchowska M; Ledóchowski A; Stezowski JJ
J Biomol Struct Dyn; 1984 Dec; 2(3):511-24. PubMed ID: 6400911
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-selective antitumor agents. 13. Effects of acridine substitution on the hypoxia-selective cytotoxicity and metabolic reduction of the bis-bioreductive agent nitracrine N-oxide.
Lee HH; Wilson WR; Ferry DM; van Zijl P; Pullen SM; Denny WA
J Med Chem; 1996 Jun; 39(13):2508-17. PubMed ID: 8691448
[TBL] [Abstract][Full Text] [Related]
7. The mode of action of cytotoxic and antitumor 1-nitroacridines. II. In vivo enzyme-mediated covalent binding of a 1-nitroacridine derivative, Ledakrin or Nitracrine, with dna and other macromolecules of mammalian or bacterial cells.
Pawlak JW; Pawlak K; Konopa J
Chem Biol Interact; 1983 Feb; 43(2):151-73. PubMed ID: 6402314
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity of nitroheterocyclic compounds, quinifuryl and nitracrine, towards leukaemic and normal cells on the dark and under illumination with visible light.
Daghastanli NA; Rossa MM; Selistre-De-Araujo HS; Tedesco AC; Borissevitch IE; Degterev IA
J Photochem Photobiol B; 2004 Jul; 75(1-2):27-32. PubMed ID: 15246347
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antitumor properties of nitracrine and amsacrine analogs.
Mazerska Z; Chołody M; Lukowicz J; Wysocka-Skrzela B; Ledóchowski A
Arzneimittelforschung; 1987 Nov; 37(11):1276-81. PubMed ID: 3326605
[TBL] [Abstract][Full Text] [Related]
10. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
Hartley JA; Spanswick VJ; Brooks N; Clingen PH; McHugh PJ; Hochhauser D; Pedley RB; Kelland LR; Alley MC; Schultz R; Hollingshead MG; Schweikart KM; Tomaszewski JE; Sausville EA; Gregson SJ; Howard PW; Thurston DE
Cancer Res; 2004 Sep; 64(18):6693-9. PubMed ID: 15374986
[TBL] [Abstract][Full Text] [Related]
11. Modulation of G(2) arrest enhances cell death induced by the antitumor 1-nitroacridine derivative, Nitracrine.
Skladanowski A
Apoptosis; 2002 Aug; 7(4):347-59. PubMed ID: 12101394
[TBL] [Abstract][Full Text] [Related]
12. Effect of intercalating and groove-binding ligands on formation of covalent complexes between nitracrine (Ledakrin, C-283) or 8-methoxypsoralen and DNA.
Wilmańska D; Małagocka E; Szmigiero L; Gniazdowski M
Biochim Biophys Acta; 1984 Jul; 782(3):285-94. PubMed ID: 6733111
[TBL] [Abstract][Full Text] [Related]
13. DNA-protein cross-linking induced by nitracrine in two strains of mouse lymphoma L5178Y cells.
Ciesielska E; Walicka M; Pastwa E; Szmigiero L
Acta Biochim Pol; 1992; 39(1):53-7. PubMed ID: 1441836
[No Abstract] [Full Text] [Related]
14. Complexes of nitracrine with DNA. Stoichiometry of binding.
Szmigiero L; Gniazdowski M
Arzneimittelforschung; 1981; 31(11):1875-7. PubMed ID: 7198467
[TBL] [Abstract][Full Text] [Related]
15. Are lethal effects of nitracrine on L5178Y cell sublines associated with DNA-protein crosslinks?
Walicka M; Szmigiero L; Ciesielska E; Gradzka I
Biochem Pharmacol; 1993 Aug; 46(4):615-20. PubMed ID: 8363635
[TBL] [Abstract][Full Text] [Related]
16. Photobiology of furocoumarins. Various types of crosslinking with DNA and their interference with the development of lambda phage.
Hradecná Z; Kittler L
Acta Virol; 1982 Sep; 26(5):305-11. PubMed ID: 6128899
[TBL] [Abstract][Full Text] [Related]
17. 32P-post-labeling analysis of DNA adduct formation by antitumor drug nitracrine (Ledakrin) and other nitroacridines in different biological systems.
Bartoszek A; Konopa J
Biochem Pharmacol; 1989 Apr; 38(8):1301-12. PubMed ID: 2706021
[TBL] [Abstract][Full Text] [Related]
18. Interactions of antitumor triazoloacridinones with DNA.
Koba M; Konopa J
Acta Biochim Pol; 2007; 54(2):297-306. PubMed ID: 17446935
[TBL] [Abstract][Full Text] [Related]
19. Anaerobic incubation and mutagenicity of nitracrine analogues in Salmonella typhimurium.
Ferguson LR; Roberton AM; Turner PM
Mutagenesis; 1987 Jul; 2(4):253-7. PubMed ID: 3325754
[TBL] [Abstract][Full Text] [Related]
20. 1,4,8-trimethylfuro[2,3-H]quinolin-2(1H)-one, a new furocoumarin bioisoster.
Marzano C; Chilin A; Baccichetti F; Bettio F; Guiotto A; Miolo G; Bordin F
Eur J Med Chem; 2004 May; 39(5):411-9. PubMed ID: 15110967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
